Inozyme Pharma
Inozyme Pharma is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of metabolic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Inozyme Pharma Information
Geographic Data
Address: 321 Summer Street
City: Boston
State: MA
Zip: 02210
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$70M
Raised Total:$220M
Social
Metrics
3,296,400Website Global Rank
4,605Website Monthly Traffic
Twitter Followers
Description
Inozyme Pharma is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of metabolic diseases.
Contact Phone:
+18573304340
Contact Email:
Inozyme Pharma went public on 7/23/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/23/2020
IPO Valuation:
$357M
Ticker Symbol:
INZY
IPO Price:
$16/share
Amount Raised:
$112M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2019 | Series A | 9 | $67.4M |
Cowen Healthcare Investments RA Capital Management Pivotal bioVenture Partners Sofinnova Investments Sanofi Ventures New Enterprise Associates Rock Springs Capital Longitude Capital Novo Holdings Pivotal bioVenture Partners Sofinnova Investments Cowen Healthcare Investments RA Capital Management Pivotal bioVenture Partners Sofinnova Investments Sanofi Ventures New Enterprise Associates Rock Springs Capital Longitude Capital Novo Holdings Pivotal bioVenture Partners Sofinnova Investments |
11/2017 | Series A | 4 | $49M |
Longitude Capital Sanofi Ventures Novo Ventures New Enterprise Associates Longitude Capital |
4/2019 | Series A | $67M |
Pivotal bioVenture Partners Sofinnova Investments RA Capital Management Rock Springs Capital Longitude Capital NEA Novo Holdings Sanofi Ventures |
7/2022 | Post-IPO Debt | 1 | $70M |
K2 HealthVentures K2 HealthVentures |
11/2018 | Venture Round | $33.7M | 7/2020 | IPO | $112M |
|
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
